Page 46 - AN-3-2

Advanced Neurology Stroke care in sub-Sahara Africa

J Stroke. 2013;8:69-75. 43. Fatunde OJ, Adamson FG, Ogunseyinde O, Sodeinde O,
Familusi JB. Stroke in Nigerian children with sickle cell
doi: 10.1111/j.1747-4949.2012.00957.x
disease. Afr J Med Sci. 2005;34(2):157-160.
33. GBD 2016 Lifetime Risk of Stroke Collaborators, Feigin VL,
Nguyen G, et al. Global, regional and country-specific 44. O’Donnell MJ, Xavier D, Liu L, et al. Risk factors for
lifetime risk of stroke, 1990 and 2016. N Engl J Med. ischemic and intracerebral hemorrhagic stroke in 22
2018;379(25):2429-2437. countries (the INTERSTATE study): A case-control study.
Lancet. 2010;376:112-123.
doi: 10.1056/NEJMoa1804492
doi: 10.1016/S0140-6736(10)60834-3
34. Akyea RK, Vinogradova Y, Qureshi N, et al. Sex, age, and
socioeconomic differences in nonfatal stroke incidence and 45. Walker RW, Jusabani A, Aris E, et al. Stroke risk factors
subsequent major adverse outcome. Stroke. 2021;52:396-405. in an incident population in urban and rural Tanzania:
A prospective, community-based, case-control study. Lancet
doi: 10.1161/STROKEAHA.120.031659 Glob Health. 2013;1(5):e282-e288.
35. Owolabi M, Sarfo F, Howard VJ, et al. Stroke in Indigenous doi: 10.1016/S2214-109X(13)70068-8
Africans, African Americans, and European Americans:
Interplay of racial and geographic factors. Stroke. 46. Okokhere PO, Bankole IA, Erohubie CA. Characteristics,
2017;48(5):1169-1175. risk factors and case fatality rate of stroke in hospitalized
patients in semi-urban South-South Nigeria. Sage Open
doi: 10.1161/STROKEAHA.116.015937 Med. 2013;1.
36. Owolabi MO, Ugoya S, Platz T. Racial disparity in stroke doi: 10.1177/2050321113516112
risk factors: Berlin-Ibadan experience, a retrospective study.
Acta Neurol Scand. 2009;119:81-87. 47. Nakibuuka J, Abwooli N, Namale A, Blondin NA,
Ddumba E. A descriptive epidemiological study on stroke
doi: 10.1111/j.1600-0404.2008.01077.x in Kampala, Uganda: A hospital-based study. Afr J Neurol
37. Edzie EKM, Gorleku PN, Dzefi-Tettey K, et al. Incidence rate Sci. 2012;31(1): 41-48.
and age of onset of first stroke from CT scan examination in 48. Geldsetzer P, Manne-Goehler J, Marcus ME, et al. The
Cape Coast Metropolis. Heliyon. 2021;7(2):e06214. state of hypertension care in 44 low-income and middle-
doi: 10.1016/j.heliyon.2021.e06214 income countries: A cross-sectional study of nationally
representative individual-level data from 1.1 million adults.
38. Tribelhorn S, Motara F, Lewis CM. Stroke: A retrospective Lancet. 2019;394:652-662.
review of the incidence and epidemiology in a South African
academic hospital emergency department. S Afr Med J. doi: 10.1016/S0140-6736(19)30955-9
2021;111(12):1205-1210. 49. GBD 2017 HIV Collaborators. Global regional and
doi: 10.7196/SAMJ.2021.v111i12.15682 national incidence, prevalence, and mortality of HIV,
1980-2017, and forecasts to 2030 for 195 countries and
39. Sarfo FS, Ovbiagele B, Gebregziabher M, et al. Stroke among territories: A systematic analysis for the Global Burden
young West Africans Evidence from the SIREN (Stroke of Disease, injuries, and risk factors study. Lancet HIV.
Investigative Research and Education Network) large 2019;6(12):e831-e859.
multisite case-control study. Stroke. 2018;49(5):1116-1122.
doi: 10.1016/S2352-3018(19)30196-1
doi: 10.1161/STROKEAHA.118.020783
50. Corbett C, Brey N, Pitcher RD, et al. Prevalence and
40. Aigwe OP, Onoja SO, Onavbavba G. A critical review of characteristics of HIV-associated stroke in a tertiary hospital
sickle cell disease burden and challenges in Sub-Sahara setting in South Africa. Neurology. 2022;99(9):e904-e915.
Africa. J Blood Med. 2023;14:367-376.
doi: 10.1212/WNL.0000000000200780
doi: 10.2147/JBM.S406196
51. Benjamin LA, Bryer A, Emsley HCA, Khoo S, Solomon T,
41. Naibiap JJ, Mengnjo MK, Nicastro N, Kamtchum- Connor MD. HIV infection and stroke: Current perspectives
Tatuene J. Neurologic complications of sickle cell disease in and future directions. Lancet Neurol. 2012;11:878-890.
Africa: A systematic review and meta-analysis. Neurology.
2017;89(14):1516-1524. doi: 10.1016/S1474-4422(12)70205-3
doi: 10.1212/WNL.0000000000004537 52. Abdallah A, Chang JL, O’Carroll CB, et al. Stroke in
human immunodeficiency virus-infected individuals in
42. Isa H, Adegoke S, Madu A, et al. Sickle cell disease clinical
phenotypes in Nigeria: A preliminary analysis of the Sickle Sub-Saharan Africa (SSA): A systematic review. J Stroke
Pan Africa Research Consortium Nigeria database. Blood Cerebrovasc Dis. 2018;27(7):1828-1836.
Cells Mol Dis. 2020;84:102438. doi: 10.1016/j.jstrokecerebrovasdis.2018.02.016
doi: 10.1016/j.bcmd.2020.102438 53. Qureshi AI, Janssen RS, Karon JM, et al. Humman

Volume 3 Issue 2 (2024) 16 doi: 10.36922/an.2804